Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report.
Saved in:
| Title: | Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report. |
|---|---|
| Authors: | Kolb EA; Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware., Houghton PJ; Greehey Children's Cancer Research Institute, San Antonio, Texas., Kurmasheva RT; Greehey Children's Cancer Research Institute, San Antonio, Texas., Mosse YP; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Maris JM; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Erickson SW; RTI International, Research Triangle Park, North Carolina., Guo Y; RTI International, Research Triangle Park, North Carolina., Teicher BA; National Cancer Institute, Bethesda, Maryland., Smith MA; National Cancer Institute, Bethesda, Maryland., Gorlick R; The University of Texas MD Anderson Cancer Center, Houston, Texas. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2020 May; Vol. 67 (5), pp. e28098. Date of Electronic Publication: 2020 Jan 23. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
